New preparation of (123I) iodolisuride from the 2-tri-n- butylstannalisuride derivative

Nuclear Medicine and Biology

Volumn 26, Issue 3, 1999, Pages 317-321

  Mauclaire, L ^a   Loc'h, C ^b   Berthommier, E ^a   Ottaviani, M ^b   Boulanger, H D ^a   Coulon, C ^b   Maziere B ^b  

^a CIS Bio International   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; RADIOLIGAND; 2 TRI N BUTYLSTANNALISURIDE; 2-TRI-N-BUTYLSTANNALISURIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IODOLISURIDE; LISURIDE; ORGANOTIN COMPOUND; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; NONHUMAN; RADIOIODINATION; RADIOISOTOPE DISTRIBUTION; RAT; REACTION ANALYSIS; SOLID PHASE EXTRACTION; ANIMAL; BRAIN; CHEMISTRY; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IODINE RADIOISOTOPES; ISOTOPE LABELING; LISURIDE; MALE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TRIALKYLTIN COMPOUNDS;

EID: 0033110793     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00103-6     Document Type: Article

References (17)

1. 123I]2-iodo-lisuride for dopamine D2-receptor studies. Nucl. Med. Biol. 23:1996;373-376.
2. Chabriat H., Levasseur M., Vidailhet M., Loc'h C., Maziere B., Bourguignon M., Bonnet A., Zilbovicius M., Raynaud C., Agid Y., Syrota A., Samson Y. In vivo SPECT imaging of D2 receptor with iodine-lisuride Result in supranuclear palsy . J. Nucl. Med. 33:1992;1481-1485.
3. Chiron C., Bulteau C., Loc'h C., Raynaud C., Garreau B., Syrota A., Maziere B. Dopaminergic D2 receptor SPECT imaging in Rett syndrome Increase of specific binding in striatum . J. Nucl. Med. 34:1993;1717-1721.
4. Cordes M., Hierholzer J., Schelosky L., Schrag A., Richter W., Eichstadt H., Schulze P.E., Poewe W., Felix R. Iodine-123-iodo-lisuride SPECT in Parkinson's disease. J. Nucl. Med. 37:1996;22-25.
5. Fuller R.H., Clemens J.A., Kornfeld E.C., Snoddy H.R., Smalstig E.B., Bach N.J. Effects of (8β)-8-methyl thiomethyl-6-propyl ergoline on dopaminergic function and brain dopamine turnover in rats. Life Sci. 24:1979;375-382.
6. Horowski R., Wachtel H. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice. Eur. J. Pharmacol. 36:1976;373-383.
7. Kessler R.M., Ansari M.S., Depaulis T., Schmidt D.E., Clanton J.A., Msith H.E., Manning R.G., Gillespie D., Ebert M.H. High affinity dopamine D2 receptor radioligands, 1. Regional rat brain distribution of iodinated benzamides. J. Nucl. Med. 32:1991;1596-1600.
8. 123I-BZM: A potent CNS D2 dopamine receptor imaging agent. J. Nucl. Med. 30:1989;88-92.
9. 123I-Iodolisuride, un nouvel agent pour l'étude des récepteurs dopaminergiques D2 par tomographie d'émission monophotonique (SPECT). J. Med. Nucl. Biophys. 15:1991;420-427.
10. 123I]-iodolisuride. J. Labelled Compd. Radiopharm. 30:1991;377.
11. Lowry O.H., Rosebrough N.J., Farr A.L. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. 76Br]-Bromolisuride A new tool for quantitative in vivo imaging of D2 dopamine receptors . Eur. J. Pharmacol. 127:1986;239-247.
13. 123I-Spiperone of high purity and high specific activity, a suitable tracer for imaging dopamine receptor sites in baboon brain with SPECT. J. Labelled Compd. Radiopharm. 26:1989;353-356.
14. Pellevoisin C., Guilloteau D., Baulieu J.L., Loc'h C., Dogon A.M., Mauclaire L., Saccavini J.C., Besnard J.C., Chalon S. Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors A comparative study . Synapse. 24:1996;79-86.
15. Seibyl J.P., Zea-Ponce Y., Brenner L., Baldwin R.M., Krystal J.H., Offord S.J., Mochoviak S., Charney D.S., Hoffer P.B., Innis R.B. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796. J. Nucl Med. 37:1996;11-15.
16. Wachtel H., Kehr W., Sauer G. Central antidopaminergic properties of 2-bromo-lisuride, an analogue of the ergot dopamine agonist lisuride. Life Sci. 33:1983;2583-2597.
17. Wagner H. N. and Wong D. F. (1990) Quantitative Imaging: Neuroreceptors, Neurotransmitters and Enzymes. Raven Press, New York, pp. 97-108.